propionylcarnitine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amico-Roxas, M; Caruso, A; Cutuli, VM; De Bernardis, E; Leonardi, G | 1 |
| Battaglia, C; Brevetti, G; Gentile, M; Golino, P; Marone, G; Oriente, A; Triggiani, M | 1 |
1 trial(s) available for propionylcarnitine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine.
Topics: Adult; Arachidonic Acids; Blood Platelets; Cardiotonic Agents; Carnitine; Eicosanoids; Humans; In Vitro Techniques; Ischemia; Male; Middle Aged; Neutrophils; Platelet Activating Factor | 1999 |
1 other study(ies) available for propionylcarnitine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
Topics: Animals; Cardiotonic Agents; Carnitine; Carrageenan; Dose-Response Relationship, Drug; Edema; Indomethacin; Male; Phenylbutazone; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |